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 For many decades, the prevalence of overweightness and obesity increased in epidemic 
proportions; currently statistics indicate that almost 3 of 4 adults in the United States are either 
overweight or obese.1  Clearly, obesity worsens most of the cardiovascular disease (CVD) risk factors, 
especially hypertension (HTN), dyslipidemia, glucose abnormalities, including metabolic syndrome and 
diabetes mellitus, and inflammation, which all increase the prevalence of coronary heart disease, a 
strong contributor along with HTN to the risk of heart failure (HF).1  Considering also the adverse effects 
that obesity have on cardiac structure and function, increasing both systolic and, more so, diastolic 
ventricular  dysfunction, it is not surprising that HF is markedly increased in the setting of obesity.1-3  
Nevertheless, many studies, including from our group,4,5 have indicated an obesity paradox in HF, where 
overweight and obese HF patients have a better short- and medium-term prognosis compared with 
leaner HF patients.6-8   
 
 Many studies have also focused on racial disparities in CVD, indicating that African Americans 
(AAs) have a significantly higher risk of CVD and its associated mortality compared with their Caucasian 
American (CA) counterparts.9  The 2013 overall death rate attributable to CVD was 223 per 100,000 
Americans, but was considerably higher for AA males (357 vs 271 per 100,000) and AA females (247 vs 
184 per 100,000) compared with CAs.10  Certainly, obesity rates are considerably higher in AAs 
compared with CAs,10 which places AAs at higher risk of HF.  However, as discussed by Krishnamoorthy 
and colleagues11 in this issue of Journal Cardiac Failure (JCF), the relationship between obesity and 
mortality in AAs is unclear, with possibly a paradoxical lower risk of death in AAs with obesity compared 
with obesity in other populations.  Likewise, although the association of obesity with HF   is well-known, 
1-3,6,9 this relationship  has not been well described in AAs . 
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 In the present issue of JCF,11 using data from the Jackson Heart Study, these investigators 
studied 5,301 AA participants, including 5,292 for mortality and 5,184 for hospitalizations.  They 
observed a higher frequency of HF as BMI increased (p < 0.001).  There was also a significant increase in 
HF hospitalizations as BMI increased, with the highest rate noted in the morbidly obese group (9%) 
compared with the lowest rate in the mildly obese participants (5.9%).  For each one unit increase in 
BMI up to 32 kg/m2, the adjusted hazard of HF hospitalization decreased by 4% (p = 0.03), whereas with 
BMI > 32 kg/m2, each one unit increase in BMI was associated with a 5% increase in HF hospitalizations 
(p < 0.001). 
 
 These investigators did not show an increase in all-cause mortality with increases in BMI in 
either unadjusted or adjusted analyses, despite the higher risk of HF and HF hospitalizations discussed 
above.  In fact, for each one unit increase in BMI up to 27 kg/m2, the adjusted hazard of all-cause 
mortality decreased by 9%.  However, there was no statistically significant association with mortality per 
one unit increase in BMI > 27 kg/m2.  In fact, in a categorical comparison with normal BMI AAs, the 
multivariable adjusted rate of all-cause mortality was 34% lower in the overweight, 30% lower in the 
obese, and even 34% lower in the morbidly obese AA group.   
 
 We recently performed a meta-analysis of 6 HF studies (n=22,807) and demonstrated the 
highest risk of adverse events, including CVD mortality, all-cause mortality, and rehospitalizations at 3-
year follow-up, were in those with the lowest BMIs, whereas the lowest risk occurred in the overweight 
BMI (Figure).5  The results in the Jackson Heart Study, however, in AAs demonstrated a discordant 
impact of obesity, especially severe obesity, to increase HF prevalence and hospitalizations, but not 
mortality,  showing lower rates of mortality even among the more severely obese.  Although recent 
studies indicate good survival in overweight and mildly obese,1,12,13 these results in AAs are different, 
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suggesting good survival even in the group with more obesity.  Nevertheless, this study did not evaluate 
mortality long-term (e.g., 10-15 years), nor did it specifically determine mortality in those with HF, 
different etiologies of HF, and those hospitalized with HF related to different BMIs.  Clearly, obesity is 
related to significant comorbidities and reduces quality of life, in addition to increased medical costs, 
including the very expensive costs of HF.1,6-8  
 
 Finally, my colleagues and I have focused on the fact that fitness may be more important than 
fatness for many health outcomes, including mortality, an observation  applicable for those with CVD, 
including HF.1,3,7,8,14  We have demonstrated that not only do AAs have lower levels of fitness than do 
CAs, AAs also appear to have less of an improvement in fitness following an exercise training program 
than do CAs.9,14-17  Since fitness is an important predictor of the development of HF and impacts its 
prognosis,18 potentially very applicable to AAs would be increasing efforts to prevent severe and morbid 
obesity and increasing levels of fitness, more so than preventing overweightness and obesity per se.  As 
is true in many aspects of medicine, the relationship between obesity and outcomes is not always "black 
and white." 
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Figure Legend 
 
Figure. Meta-analysis of six studies (n=22,807) on impact of body mass index on cardiovascular 
mortality, all-cause mortality, and hospitalizations in heart failure. Reproduced with permission from 
Sharma A et al, Am J Cardiol.5  
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